Page 2 - இம்யூனோ உயிரியல் ஆய்வகங்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இம்யூனோ உயிரியல் ஆய்வகங்கள் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இம்யூனோ உயிரியல் ஆய்வகங்கள் இன்க் Today - Breaking & Trending Today

Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio


Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio
Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background
RENSSELAER, N.Y., Jan. 18, 2021 (GLOBE NEWSWIRE) Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio.
Immuno-oncology is a leading research priority because it uses the body s own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role because they use standard inbred mice that have a competent immune system, which is required to evaluate immune-modulating therapies. These models are engrafted with mouse tumors derived from the same strain background; this genetic similarity between tumor and host prevents the host from rejecting the tumor. ....

Michael Seiler , Taconic Biosciences , Kostenloser Wertpapierhandel , Kelly Owen Grover , Taconic Jh , Marketing Communications , Taconic Biosciences Inc , மைக்கேல் சீலர் , டகோனிக் உயிர் அறிவியல் , கெல்லி ஓவந் தோப்பு , டகோனிக் ஜ் , சந்தைப்படுத்தல் தகவல்தொடர்புகள் , டகோனிக் உயிர் அறிவியல் இன்க் ,

ImaginAb To Supply 89Zr CD8 Immuno-PET Agent To Pfizer


ImaginAb To Supply 89Zr CD8 Immuno-PET Agent To Pfizer
NEW YORK CITY (dpa-AFX) - ImaginAb, a provider of immuno-oncology imaging agents, has signed a non-exclusive license with Pfizer Inc. (PFE) to supply 89Zr CD8 Immuno-PET agent, which can be used to image CD8 T cells in cancer patients. ImaginAb will supply clinical doses of 89Zr CD8 Immuno-PET agent to Pfizer for use in select oncology clinical trials. ImaginAb will also provide technical, clinical, and regulatory support to Pfizer. ImaginAb will receive license fees and payments for manufacturing and other support.
ImaginAb Inc. is biotechnology company focused on developing radiopharmaceutical imaging and therapy agents. It is backed by top tier venture capital firms and strategic corporate firms. ....

Pfizer Inc , Imaginab Inc , ஃபைசர் இன்க் ,